The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
Studies dispute ultraviolet effect on amphibian population declines

e EPA and the National Park Service's Canon National Parks Science Scholars Program helped pay for the research.

The same edition of Ecology includes a second, corroborating study, by USGS researchers P. Stephen Corn and Erin Muths, that examines breeding of the boreal chorus frog at a Colorado pond.

The research by Palen's group used amphibian population and breeding information scientists collected at hundreds of Pacific Northwest sites from 1997 through 2000. The focus was narrowed to 136 sites that yielded the best information, and then water samples were collected from each of those sites, spread throughout the Olympic Mountains and the Cascade Range in Washington and Oregon.

The water samples were analyzed for dissolved organic matter produced primarily from terrestrial vegetation and soils that is leeched into lakes and streams by rain or melting snow. The research concluded that 85 percent of the amphibian habitats sampled are protected from harmful levels of UV-B by dissolved organics.

Using the water-sample approach allowed the scientists to bring the small scale at which experiments are done into line with the much larger scale at which conditions could affect entire populations.

Most of the previous research that implicated UV-B in amphibian mortality and deformity has been done in the Northwest, but the effects were thought to occur elsewhere as well. Now, Palen said, it appears that scientists need to keep looking for causes, and that they could include a number of factors that vary across geographic regions.

For instance, she noted that the mountain yellow-legged frog in California's Sierra Nevada has been declared endangered, but the reason has nothing to do with UV-B. Instead, the frog population has declined because of the introduction of non-native trout species that feed on frog eggs, juveniles and adults.

Such evidence suggests that the causes of amphibian population declines might be spe
'"/>

Contact: Vince Stricherz
vinces@u.washington.edu
206-543-2580
University of Washington
5-Dec-2002


Page: 1 2 3

Related biology news :

1. Monkey business: Studies show tiny callimicos have unusual characteristics
2. Studies show success of Mectizan partnerships
3. Studies offer new insight into HIV vaccine development
4. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
5. Studies show preventive value of food supplements
6. Studies probe rapid evolution of Chinese tallow trees
7. Studies of rare blood syndrome yield novel route to cancer
8. Studies of spiders silk reveal unusual strength
9. Studies of genes in mice and common worm may accelerate research on blood diseases, cancers
10. Studies offer data on potential impact of Reminyl on caregiver burden in Alzheimers disease
11. Studies: Floyd, other major hurricanes of 99 caused significant changes in nations largest lagoonal estuary

Post Your Comments:
(Date:11/23/2009)...RE, Calif. - By producing some of the highest reso...faces, scientists have a deeper understanding how ...research may lead to a new treatment for kidney st...ppears in the Nov. 23 online edition of the journa... , explores how peptides interact with mineral sur...
(Date:11/23/2009)...MINGHAM, Ala. A new study by University of Alabam...mass index (BMI) and co-existing medical condition...ival observed among African-Americans compared to ...s published online Nov. 23 in Cancer , a journal ...dicates that although BMI and co-morbidity are ind...
(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18
(Date:11/24/2009)...ntly approved the Promega PowerPlex 16 HS System f...ing DNA records for the National DNA Index System....) -- The FBI recently approved the Promega PowerP...ticipating in, or generating DNA records for, the ...ontains more than seven million profiles and has a...
(Date:11/24/2009)...irstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegl...cedthatithassubmittedaMAAtotheEuropeanMedicinesAge...menttherapyindevelopment,forthetreatmentofType1Gau...velaglucerasealfathathasbeensubmitted,withprevious...edonaglobalsupplyshortageofthecurrentlyapprovedand...
(Date:11/24/2009)...ire/--HealthRoboticstodayannounced,thatithasformed...tors.ThisrecentlyformedToronto-basedcompanywillope...arket,install,andsupport,HealthRobotics,i.v.Roomof...ductofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(T...nceonan"asneeded,basis"toitsstrategicpartnershipsw...
(Date:11/24/2009)...tCall/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CT...yHealthCareConference.TheconferencewillbeheldDecem...presentonTuesday,December1at11:00a.m.EasternTimein...tionwillbeavailableat www.celltherapeutics.com ,an...erJaffrayHealthCareConference,NewYorkPalaceHotel,H...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
Other News:
...ole in the molecular machinery for making HIV-1 (t...scientists from the National Institute of Standard... working at the Center for Advanced Research in Bi...the mechanism, described in the Jan. 20 online edi...
...the Stanford Synchrotron Radiation Laboratory (SSR...acility, SPEAR3, guarantees a world-class program ...retary of Energy Spencer Abraham. "This is the fir...Institutes of Health have joined in funding an acc...
..., Low Cholesterol Diets......It is well known that...reased risk for coronary heart disease a major ca...erapeutic approach is to follow a diet low in satu...fect of this therapeutic diet on cholesterol respo...
...launched a new initiative to speed research on ner... that attacks the brain and spinal cord. The Socie...mpete for grants of up to $5.5 million each to pav...ction strategies in people with MS. ......"The pac...
Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 2Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 3Highlights of Tufts University nutrition research: January 2004 2Highlights of Tufts University nutrition research: January 2004 3Highlights of Tufts University nutrition research: January 2004 4
..., 2005 -- Results from a Phase 2 rheumatoid arthri...f golimumab (CNTO 148), a fully-human anti-TNF-alp...dpoint of the study. In this dose-ranging trial, ...o severely active RA treated with golimumab and me...
...s with the University of Florida and the Californi...ain of genetically modified mice that allow scient...erapies for Alzheimer's disease.......The developm...cess medical journal PloS Medicine, has helped sci...
It sounds like science fiction: simply swallowing a pill, or eating a specific food supplement, could permanently change your behaviour for the better, or reverse diseases such as schizophrenia, Hunti
...ardiology researchers at Cedars-Sinai Medical Cent...s virus engineered to carry a beneficial, mutant g...y of the gene's protein product that protects agai...the amount of plaque was significantly reduced, as...
Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 2Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 3Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 4Scientists engineer mice to mimic Alzheimer's therapy 2The food you eat could change your genes 2The food you eat could change your genes 3Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 2Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 3